Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
Advertisement

Healthcare

This Month

Mental health remains a serious issue after a pandemic year.

Nearly half of Australians chronically sick

A surge in mental health diagnoses has pushed the number of people with chronic conditions to the highest level since records began.

  • Euan Black
Mark Finocchiaro, managing partner Chemist Warehouse, owns eight pharmacies in the group.

Inside the Chemist Warehouse franchisee world

There are over 200 managing partners who are shareholders in the discount chain. They are all ambitious pharmacy owners, many with multiple sites.

  • Carrie LaFrenz
Healius shares rose sharply during the COVID-19 pandemic but have lost $2b in market value.

ACL pulls Healius bid as ACCC blocks pathology shake-up

Australian Clinical Labs, the No.3 player in the pathology market, has not given up in its chase for ailing No.2 player Healius.

  • Simon Evans
Brian Hartzer is returning to the executive ranks.

Brian Hartzer’s warning to AI wannabes

The former Westpac boss, who is now CEO of Quantium Health, says effective AI use for companies is all about balance. 

  • Updated
  • James Thomson
Christmas can be difficult if you have given up drinking.

Eight tips to survive Christmas if you’ve stopped drinking

The holidays can be incredibly difficult to navigate if you’ve decided to give up alcohol. Here’s what a sobriety expert recommends.

  • Richard Piper
Advertisement
Founders of men’s health tech startup Mosh, David Narunsky and Gabe Baker.

Men’s health player Mosh appoints adviser to explore exit options

Gavin Jacobson’s advisory firm has won the sell-side mandate to explore options for Mosh.

  • Sarah Thompson, Kanika Sood and Emma Rapaport
Sigma Healthcare CEO Vikesh Ramsunder, and Chemist Warehouse co-founder, Mario Verrocchi (R) both will remain in the combined business valued at $8.8 billion.

Sigma could shed customers after Chemist Warehouse merger

The deal, creating an $8.8 billion retail and wholesaling giant, could even be blocked by competition regulators, according to analysts at Morningstar.

  • Carrie LaFrenz and Tom Richardson
Disability Minister Bill Shorten in question time.

NDIS overhaul to weed out profiteers and price gougers

The long-awaited review of the disability scheme demands higher standards of service providers and recommends measures to eradicate overservicing and fraud.

  • Phillip Coorey and Michael Read
Jack Gance and Mario Verrocchi are set to storm onto the ASX boards.

Why the $8b Chemist Warehouse deal is historic and creative

Chemist Warehouse founders Jack Gance and Mario Verrocchi and HMC boss David Di Pilla have cooked up an unorthodox way to finally get the retail giant onto the ASX boards.

  • James Thomson
Medibank chief executive David Koczkar.

Medibank Private secures binding deal to lift Myhealth stake

It is understood the listed insurer will go from owning about 33.3 per cent of the GP clinics chain to 66.66 per cent at a $260 million valuation.

  • Sarah Thompson, Kanika Sood and Emma Rapaport
Melbourne man Martin Skoneczko, 55, is sick of “unnecessary middlemen” and “fraudulent providers” in the NDIS.

‘Fraudulent’: NDIS firm quotes $40k for ramp that cost $11k

Unscrupulous NDIS providers are seeking to take advantage of the scheme’s vague promise to provide care that is ‘reasonable and necessary’.

  • Updated
  • Gus McCubbing
Healius CEO Maxine Jaquet at the annual meeting on November 28.

Why it’s so hard to make money from blood tests

There’s restructuring ahead at the No. 2 pathology provider Healius, which despite its activist ructions, has yielded a 30 per cent return since its 2023 low.

  • Simon Evans

November

Former St Vincent’s chief executive and freshly minted 
Integral Diagnostics chair Toby Hall.

Integral Diagnostics chair pops up for Partners Group at Cura auction

The Zug-headquartered private equity firm is serious about its tilt as it jostles with Intermediate Capital Group and a Medibank/Macquarie consortium.

  • Sarah Thompson, Kanika Sood and Emma Rapaport

This moonshot tech firm is Australia’s fastest growing company

Fleet Space Technologies, with a compound annual growth rate of 582 per cent over three years, is top of the Fast 100 class for 2023.

  • Michael Bailey
Chris Nasr and Grace Tan, founders of Nectar Brands.

Meet the Fast Starters building healthcare empires

Health companies make up about 10 per cent of this year’s list, reflecting demand for better, cheaper and more convenient access to products and services.

  • Ronald Mizen
Advertisement
The details of patients’ tests were leaked on to the dark web after the ACL breach.

Sexual health and fertility details leaked in ACL data breach

ASX-listed pathology provider Australian Clinical Labs faces potentially millions of dollars in fines for failing to protect sensitive financial and health data.

  • Paul Smith
Healius chairwoman Jenny Macdonald at the annual meeting on Tuesday.

Healius chairwoman exits without apology for $2b wipeout

Departing Healius chairwoman Jenny Macdonald understands shareholder “frustration” but would not apologise for $2b of value destruction.

  • Simon Evans
Healius big shareholders’ No.1 ask of the new chair is to fix operating performance.

Healius chair’s head on a stick shows investors out of patience

If the healthcare company can’t pull up its socks in the medium term, expect investors to push the board to think about other ways to realise value.

  • Anthony Macdonald
Marc Hermann, co-founder of Everlab, with a client of his start-up, which quantifies people’s health by measuring things such as their levels of sleep, blood sugar and oxygenation.

How the tech crowd track their health to live longer

‘Quantified self’ is a movement where the health conscious are trying to leave nothing to chance, using the latest in technology to monitor their bodies and fitness.

  • Nick Bonyhady
Cura runs a string of day surgeries around the country.

Final bids for $500 million-plus Cura auction; doctors weigh in

Intermediate Capital Group, Partners Group and Macquarie Capital-advised Medibank are jostling for the doctor-owned day surgery network.

  • Sarah Thompson, Kanika Sood and Emma Rapaport